ONCOPANELS.COM

Insilico Medicine, Inc. is a bioinformatics company located at the Emerging Technology Centers at Johns Hopkins University in Baltimore. It utilizes the advances in multi-omics big data analysis for in silico drug discovery and drug repurposing for aging and age-related diseases. The company utilizes the GeroScope(TM), OncoFinder(TM), Pathway Cloud Intelligence(TM) and PharmAtlas(TM) packages for aging and cancer research, pursues internal drug discovery programs, and provides services to pharmaceutical companies... Insilico Medicine has conducted a comprehensive in silico screening of compounds from ChemDiv database with high potential in oncological treatment. Insilico Medicine predictions are based on thorough understanding of molecular pathways affected by each compound as well as molecular pathways indicative of specific cancer types.